Moderate aLimited use in the US/Europe. bNot licensed in the US cPrescribing highly
restricted in the US; withdrawn in Europe. dNot licensed in Europe. eTo be available as a …

Metabolic syndrome (MetS), today a major global public health problem, is a cluster of
clinical, metabolic, and biochemical abnormalities, such as central adiposity, hypertension …

Background Insulin icodec (icodec) is a once-weekly basal insulin currently under
development. ONWARDS 2 aimed to assess the efficacy and safety of once-weekly icodec …

Exosomes are nanosized extracellular vesicles (EVs) that show great promise in tissue
regeneration and injury repair as mesenchymal stem cell (MSC). MSC has been shown to …

Exosomes are extracellular vesicles with the size of 40–100 nm in diameter and a density of
1.13–1.19 g/mL, containing proteins, mRNAs, miRNAs, and DNAs. Exosomes change the …

Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …

Over the past 2 decades, mesenchymal stem cells (MSCs) have attracted a lot of interest as
a unique therapeutic approach for a variety of diseases. MSCs are capable of self-renewal …

Abstract Type 2 diabetes (T2DM) is a leading cause of morbidity and mortality worldwide
and a major economic burden. The prevalence of T2DM is rising, suggesting more effective …

The chronic metabolic disorder diabetes mellitus is a fast-growing global problem with huge
social, health, and economic consequences. It is estimated that in 2010 there were globally …

Objective The purpose of this work was to meta-analyze prospective studies that have
evaluated the effect of a Mediterranean diet on the development of type 2 diabetes …